Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Value Type Interaction Map description Rank Network Comparison Type Gene Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 2225 to 2274 of 3228 in total 
Value Type: Measured
Interaction Map: High confidence
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein-tyrosine phosphatase beta precursor (ec 3.1.3.48) (r-ptp- beta). [source:swissprot;acc:p23467]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
538\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
10603.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12069.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.13825\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein-tyrosine phosphatase, non-receptor type 1 (ec 3.1.3.48) (protein-tyrosine phosphatase 1b) (ptp-1b). [source:swissprot;acc:p18031]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1247\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6278.76\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6807.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08421\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein-tyrosine phosphatase, non-receptor type 11 (ec 3.1.3.48) (protein-tyrosine phosphatase 2c) (ptp-2c) (ptp-1d) (sh-ptp3) (sh- ptp2) (shp-2). [source:swissprot;acc:q06124]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2789\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein-tyrosine phosphatase, non-receptor type 2 (ec 3.1.3.48) (t- cell protein-tyrosine phosphatase) (tcptp). [source:swissprot;acc:p17706]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1248\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6275.86\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6803.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08415\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
proto-oncogene c-crk (p38) (adapter molecule crk). [source:swissprot;acc:p46108]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
248\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6417.18\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7859.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.22477\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
proto-oncogene protein c-fos (cellular oncogene fos) (g0/g1 switch regulatory protein 7). [source:swissprot;acc:p01100]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
83\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4932.27\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7033.29\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.42597\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
proto-oncogene tyrosine-protein kinase abl1 (ec 2.7.1.112) (p150) (c-abl). [source:swissprot;acc:p00519]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
253\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6417.18\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7859.59\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.22477\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
proto-oncogene tyrosine-protein kinase fer (ec 2.7.1.112) (p94-fer) (c-fer). [source:swissprot;acc:p16591]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1649\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6079.19\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6503.12\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06973\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
proto-oncogene tyrosine-protein kinase fes/fps (ec 2.7.1.112) (c-fes). [source:swissprot;acc:p07332]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1645\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
proto-oncogene tyrosine-protein kinase fgr (ec 2.7.1.112) (p55-fgr) (c-fgr). [source:swissprot;acc:p09769]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
255\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6417.18\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7859.6\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.22477\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
proto-oncogene tyrosine-protein kinase fyn (ec 2.7.1.112) (p59-fyn) (syn) (slk). [source:swissprot;acc:p06241]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
254\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
proto-oncogene tyrosine-protein kinase src (ec 2.7.1.112) (p60-src) (c-src). [source:swissprot;acc:p12931]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
250\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protocadherin 15 precursor. [source:swissprot;acc:q96qu1]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1181\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4392.63\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4776.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08732\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protocadherin 16 precursor (cadherin 19) (cadherin fibroblast 1). [source:swissprot;acc:q96jq0]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2838\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protocadherin fat 2 precursor (hfat2) (multiple epidermal growth factor-like domains 1). [source:swissprot;acc:q9nyq8]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1722\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5458.12\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5830.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06827\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protoheme ix farnesyltransferase, mitochondrial precursor (ec 2.5.1.-) (heme o synthase). [source:swissprot;acc:q12887]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
933\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5638.46\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6194.04\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09853\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protoporphyrinogen oxidase (ec 1.3.3.4) (ppo). [source:swissprot;acc:p50336]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2934\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
prp18 pre-mrna processing factor 18 homolog. [source:refseq;acc:nm\_003675]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2707\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8979.61\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9012.31\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00364\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ptb domain adaptor protein ced-6; engulfment adapter protein. [source:refseq;acc:nm\_016315]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
364\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5189\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6088.47\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.17334\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ptd016 protein. [source:refseq;acc:nm\_016125]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3093\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
purine nucleoside phosphorylase (ec 2.4.2.1) (inosine phosphorylase) (pnp). [source:swissprot;acc:p00491]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1444\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5450.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5869.07\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07672\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
puromycin-sensitive aminopeptidase (ec 3.4.11.-) (psa). [source:swissprot;acc:p55786]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
828\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5745.61\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6354.75\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10602\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
putatative 28 kda protein. [source:refseq;acc:nm\_020143]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2747\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4708.68\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4702.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0013\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
putative acyl-coa thioester hydrolase cgi-16 (ec 3.1.2.-). [source:swissprot;acc:q9y305]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1060\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5719.01\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6248.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0926\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
putative adenosylhomocysteinase 2 (ec 3.3.1.1) (s-adenosyl-l- homocysteine hydrolase) (adohcyase). [source:swissprot;acc:o43865]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
626\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6228.39\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7013.19\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.126\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
putative adenosylhomocysteinase 3 (ec 3.3.1.1) (s-adenosyl-l- homocysteine hydrolase) (adohcyase). [source:swissprot;acc:q96hn2]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
628\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
putative ankyrin-repeat containing protein. [source:refseq;acc:nm\_025185]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1720\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5458.12\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5830.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06827\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
putative breast adenocarcinoma marker (32kd). [source:refseq;acc:nm\_014453]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
147\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
11068\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8508.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.30082\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
putative dimethylaniline monooxygenase [n-oxide forming] 6 (ec 1.14.13.8) (flavin-containing monooxygenase 6) (fmo 6) (dimethylaniline oxidase 6). [source:swissprot;acc:o60774]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
952\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5364.3\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5885.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09716\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
putative eukaryotic translation initiation factor 1a (eif-1a) (eif- 4c). [source:swissprot;acc:o75642]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2439\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3754.39\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3629.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03441\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
putative eukaryotic translation initiation factor 3 subunit (eif-3) (fragment). [source:swissprot;acc:o75153]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1193\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5464.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5940.16\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08697\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
putative glialblastoma cell differentiation-related; putative glialblastoma cell differentiation-related protein. [source:refseq;acc:nm\_016172]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
291\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
44490.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
36927.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.20481\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
putative gtp-binding protein ptd004 (pro2455). [source:swissprot;acc:q9ntk5]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2089\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5775.22\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6094.89\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05535\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
putative inorganic polyphosphate/atp-nad kinase (ec 2.7.1.23) (poly(p)/atp nad kinase). [source:swissprot;acc:o95544]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1639\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5939.71\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6354.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06988\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
putative membrane protein. [source:refseq;acc:nm\_019026]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2935\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
putative mitochondrial solute carrier; hypothetical protein npd016; putative mitochondrial solute carrier. [source:refseq;acc:nm\_031212]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2891\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
putative n6-dna-methyltransferase (ec 2.1.1.-) (protein pred28) (m.hsahemk2p). [source:swissprot;acc:q9y5n5]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
793\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5036.92\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5596.36\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11107\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
putative nadh oxidoreductase complex i subunit homolog. [source:sptrembl;acc:q96q80]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3146\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
putative nucleoside diphosphate kinase (ec 2.7.4.6) (ndk) (ndp kinase). [source:swissprot;acc:o60361]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
637\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7756.51\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8731.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12573\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
putative phosphoglycerate mutase 3 (ec 5.4.2.1) (ec 5.4.2.4) (ec 3.1.3.13). [source:swissprot;acc:q8n0y7]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1112\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5910.54\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6440.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08968\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
putative pre-mrna splicing factor rna helicase (atp-dependent rna helicase #3) (deah-box protein 16). [source:swissprot;acc:o60231]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2319\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6362.48\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6647.42\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04478\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
putative pre-mrna splicing factor rna helicase (deah box protein 15) (atp-dependent rna helicase #46). [source:swissprot;acc:o43143]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
349\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4714.85\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5554.38\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.17806\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
putative ribosomal rna methyltransferase 1 (ec 2.1.1.-) (rrna (uridine-2'-o-)-methyltransferase) (jm23 protein). [source:swissprot;acc:q9uet6]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1607\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5232.99\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5606.53\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07138\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
putative rna-binding protein 15 (rna binding motif protein 15) (one-twenty two protein). [source:swissprot;acc:q96t37]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
276\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3119.98\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2579.49\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.20953\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
putative rna-binding protein 7 (rna binding motif protein 7). [source:swissprot;acc:q9y580]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2134\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5328.73\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5616.59\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05402\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
putative sialoglycoprotease type 2. [source:refseq;acc:nm\_022353]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
992\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5393.37\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5909.47\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09569\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
putative tumor suppressor 101f6. [source:refseq;acc:nm\_007022]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3051\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pwwp domain containing 1; hdgf (hepatoma-derived growth factor) like. [source:refseq;acc:nm\_138574]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
388\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4533.74\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5279.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16447\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pxr2b protein. [source:refseq;acc:nm\_016559]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1929\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6996.51\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7429.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06184\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pyridoxine 5'-phosphate oxidase. [source:refseq;acc:nm\_018129]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1272\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5528.65\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5985.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08265\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/